Method for mechanical and hydrodynamic microfluidic transfection
11306284 · 2022-04-19
Assignee
Inventors
Cpc classification
B81B2201/058
PERFORMING OPERATIONS; TRANSPORTING
C12N2740/15043
CHEMISTRY; METALLURGY
C12M35/04
CHEMISTRY; METALLURGY
C12N15/87
CHEMISTRY; METALLURGY
C12N2521/00
CHEMISTRY; METALLURGY
C12M35/00
CHEMISTRY; METALLURGY
B81B1/00
PERFORMING OPERATIONS; TRANSPORTING
International classification
C12N15/87
CHEMISTRY; METALLURGY
B81B1/00
PERFORMING OPERATIONS; TRANSPORTING
C12M3/06
CHEMISTRY; METALLURGY
Abstract
Methods for introducing exogenous material into a cell are provided, which include exposing the cell to a transient decrease in pressure in the presence of the exogenous material. Also provided are devices for performing the method of the invention.
Claims
1. A method introducing an exogenous material into a cell, comprising: inducing a first condition around the cell where there is a first ambient pressure insufficient to lyse the cell; inducing a second condition around the cell where a second ambient pressure is less than the first ambient pressure; and inducing a third condition around the cell where a third ambient pressure is greater than the second ambient pressure, the third condition being induced while the cell is in an unsteady flow, which creates a permeabilized cell membrane, allowing the exogenous material to be introduced into the cell.
2. The method of claim 1, wherein the second condition is induced in less time than the third condition.
3. The method of claim 1, wherein at least one of the second and third conditions is induced under unsteady flow conditions, which temporarily cause an extracellular pressure that is greater than an intracellular pressure and permeabilises a cell membrane.
4. The method of claim 1, wherein the third condition is induced by pulsing the cell with an unsteady flow.
5. The method of claim 1, further comprising repeatedly pulsing the cell with an unsteady flow to facilitate delivery of the exogenous material into the cell.
6. The method of claim 1, wherein the cell is viable after the introduction of the exogenous material into the cell.
7. The method of claim 1, wherein the exogenous material is selected from the group consisting of an organic molecule, a physiologically acceptable organic molecule derivative, a biomolecule, a physiologically acceptable biomolecule derivative, a physiologically acceptable biomolecule analogue, an inorganic molecule, physiologically acceptable inorganic molecule derivative, a quantum dot, a carbon nanotube, a nanoparticle, and a gold particle.
8. The method of claim 7, wherein the biomolecule is selected from the group consisting of a carbohydrate, a lipid, an amino acid, a peptide, a protein, a nucleotide, and a nucleic acid.
9. The method of claim 8, wherein the nucleic acid is selected from the group consisting of a deoxyribonucleic acid and a ribonucleic acid.
10. The method of claim 8, wherein the nucleic acid is included in an expression vector.
11. The method of claim 10, wherein the expression vector is a plasmid.
12. The method of claim 10, wherein the expression vector comprises at least one regulatory sequence.
13. The method of claim 12, wherein the at least one regulatory sequence is selected from the group consisting of an enhancer region and a promoter region.
14. A method for introducing exogenous material into a cell, comprising: exposing the cell to a first pressure change under unsteady flow conditions, where the extracellular pressure is different than the intracellular pressure, to temporarily permeabilise the cell membrane without the cell becoming lysed; and exposing the cell to a second pressure change under unsteady flow to introduce the exogenous material into the cell, the first pressure change being a negative pressure change, the second pressure change being a positive pressure change along with unsteady flow.
15. The method of claim 14, wherein the first pressure change decreases extracellular pressure relative to the first pressure of surrounding the cell.
16. The method of claim 14, wherein the second pressure change increases the extracellular pressure relative to the intracellular pressure of the cell.
17. The method of claim 14, wherein the second pressure change is induced by pulsing the cell with an unsteady flow.
18. The method of claim 14, further comprising repeatedly pulsing the cell—with an unsteady flow to facilitate delivery of the exogenous material into the cell.
19. The method of claim 14, wherein the cell is viable after the introduction of the exogenous material into the cell.
20. The method of claim 14, wherein the exogenous material is selected from the group consisting of an organic molecule, a physiologically acceptable organic molecule derivative, a biomolecule, a physiologically acceptable biomolecule derivative, a physiologically acceptable biomolecule analogue, an inorganic molecule, physiologically acceptable inorganic molecule derivative, a quantum dot, a carbon nanotube, a nanoparticle, and a gold particle.
21. The method of claim 20, wherein the biomolecule is selected from the group consisting of a carbohydrate, a lipid, an amino acid, a peptide, a protein, a nucleotide, and a nucleic acid.
22. The method of claim 21, wherein the nucleic acid is selected from the group consisting of a deoxyribonucleic acid and a ribonucleic acid.
23. The method of claim 21, wherein the nucleic acid is included in an expression vector.
24. The method of claim 23, wherein the expression vector is a plasmid.
25. The method of claim 23, wherein the expression vector comprises at least one regulatory sequence.
26. The method of claim 25, wherein the at least one regulatory sequence is selected from the group consisting of an enhancer region and a promoter region.
27. The method of claim 1, further comprising introducing the exogenous material into the cell during the third condition.
28. The method of claim 1, wherein the cell is transported in a liquid medium while the first, second, and third conditions are induced.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
(11) Some figures contain color representations or entities. Color illustrations are available from the Applicant upon request or from an appropriate Patent Office. A fee may be imposed if obtained from the Patent Office.
DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS OF THE INVENTION
(12) Although the invention has been described with reference to certain embodiments detailed herein, other embodiments can achieve the same or similar results. Variations and modifications of the invention will be obvious to those skilled in the art and the invention is intended to cover all such modifications and equivalents.
(13) The invention is further described by the following non-limiting examples.
Example 1
(14) A method and device of the invention was assessed by transfecting a cell model with pcDNA 3.1 (Invitrogen™), which expresses green fluorescent protein (GFP). The device used was a microfluidic device configured with an array of posts, wherein the gap between posts was greater than the cell diameter.
(15) Methods
(16) Simulation & Analysis
(17) Simulation by computation fluid dynamics (CFD) with the finite-volume method was employed to examine the microenvironment around the gaps between posts for the parameters shown in Table 1 and the device geometry shown in
Re.sub.c=2ρQ/μ(g+h)
(18) The boundary conditions for the channel top, bottom and walls defined by posts were set to no slip. Boundary conditions for fluidic sidewalls were set to zero shear. Inlet velocity was defined by an average velocity and the outlet was set to a zero pressure boundary condition.
(19) TABLE-US-00001 TABLE 1 Summary of experimental parameters. Parameter Value Cell type HEK293 Cell density 1 × 10.sup.5 cells ml.sup.−1 Cell diameter (d.sub.c) 13 μm Flourescent molecule pcDNA 3.1 (GFP plasmid) Molecule density 890 ng ml.sup.−1 Channel height (h) 40 μm Channel width (w) 400 μm Post diameter (d.sub.p) 20 μm Post gap (g) 30 μm Row shift (s) 0 μm Row pitch (p.sub.r) 50 μm Rows (n.sub.r) 9 posts Column pitch (p.sub.c) N/A Columns (n.sub.c) 1 post Media viscosity (μ) 7.987 × 10.sup.−4 Pa s Media density (ρ) 1,006 kg m.sup.−3 Flow rate (Q) 5 ml min.sup.−1 Channel Reynolds number (Re.sub.c) 375 Object Reynolds number (Re.sub.o) 131 Oscillating frequency (f) 44.4 kHz
(20) Master moulds of microfluidic devices were fabricated using standard photolithography techniques, while devices were replicated using soft lithography and bonded to glass using oxygen plasma. An overview of the device design and transfection parameters are shown in
(21) HEK293 (Human embryonic kidney 293) cells were suspended in cell media at a density of 1×10.sup.5 cells ml.sup.−1, and pcDNA 3.1 GFP plasmids were seeded at a density of 890 ng ml.sup.−1. This suspension was loaded into a syringe and pumped into the microfluidic device with a flow rate of 5 ml min.sup.−1, which corresponds to a Re.sub.c of 375 at the gap between posts as the flow cell contained an array of 8 units separated with a 20 μm diameter post with a gap between posts of 30 μm. This also corresponds to a Re.sub.o of 131. Subsequently, cells were incubated for a period of 6 days then imaged via both fluorescent and optical microscopy to examine green fluorescent protein gene expression.
(22) Results
(23) Simulation & Analysis
(24) Simulations indicated a high-pressure region occurs just upstream of the posts in the device of
(25) According to the simulations, as a cell passed through a gap between posts positioned in the enclosed channel of the device, it moves from a surrounding zone with a localised pressure of 43.5 kPa, is exposed to a transient decrease in pressure of 94.3 kPa as it enters a zone of relatively lower pressure, which has a minimum pressure of −50.8 kPa. The magnitude of the transient decrease in pressure may vary depending on the phase of the oscillation. Additionally, cell velocity in the liquid is estimated to be 15 m s.sup.−1 during this transient decrease in pressure, which occurs over a distance of approximately 40 μm for a transient decrease in pressure (dP/d.sub.t) of −35.4×10.sup.6 kPa s.sup.−1, wherein dP/d.sub.t is the change is pressure (dP) over change in time (d.sub.t). dP is change in pressure between local maxima and local minima. d.sub.t is change in time between local maxima pressure and local minima.
(26) Subsequently, the unsteady flow conditions subject the cell rapidly changing flow velocities in the direction orthogonal (y-direction) to the direction the cell is moving (x-direction), as shown in
(27) The simulations suggest the exposure to unsteady flow creates a pressure drop across the cell membrane where the local extracellular pressure is greater than the local intracellular pressure, thereby facilitating active (mechanical) delivery. Additionally, the increase in pressure as the cell moves towards the device outlet suitably to facilitates active delivery due to the pressure drop across the permeabilised cell membrane.
(28) Transfection
(29) As shown in
(30) The simulations allow for unsteady flow, and preliminary simulations were used to determine which velocity was the most appropriate for calculating Re.sub.o based on the transition from laminar flow conditions to unsteady flow conditions. The velocity of the liquid used for calculating Re.sub.o varies in the literature, however, previous simulations confirm the mean upstream velocity is the appropriate velocity. For example, for liquid flow around a cylindrical post the object Reynolds number (Re.sub.o) may be calculated with the equation below:
Re.sub.o=ρv∞d/μ
where v∞ refers to the velocity of a bulk liquid relative to the cylindrical post, and in this case, the mean upstream velocity of the liquid before the cylindrical post. This would be 8.68 m s.sup.−1 for the parameters shown in Table 1, resulting in an Re.sub.o of 131.2.
(31) In order to estimate the frequency of oscillation, the correlation shown below is used as it applies to flow of liquid around cylindrical posts, where the Re.sub.o is between 40 and 190. The Strouhal number (Sr) (a dimensionless number used to describe unsteady flow) maybe calculated from Re.sub.o with the following correlations for flow around a cylindrical post:
Sr=0.2665−1.018/√Re.sub.o for (40<Re.sub.o<190)
(32) This calculation results in a Sr of 0.17, and the frequency of oscillation (f) may be calculated with the equation below with the liquid velocity (v) and characteristic length (L), which is equal to the diameter of the post (d.sub.p):
f=Srv/d.sub.p
(33) For the parameters described above, it is estimated the unsteady flow oscillates at a frequency of 44.4 kHz. These unsteady oscillations are also known to induce structural vibrations within the posts themselves. Thus, it is believed cells may be exposed to a transient decrease in pressure, 44.4 kHz unsteady flow along with induced structural vibrations.
(34) Laminar flow (Re>>1) between one or more flow diverters, such as (but not limited to) posts, may be used to create a region of transiently decreased pressure substantially immediately downstream of the posts. This may be used to suddenly and temporarily decrease ambient pressure surrounding a cell as it flows past the posts of devices such as those shown in
Example 2
(35) Experiments were performed to investigate the extent to which the magnitude and duration of the decrease in pressure affects transfection.
(36) Methods
(37) Two cultures of HEK293 cells were seeded at a density of 100,000 cells ml.sup.−1, wherein culture 1 contained HEK293 cells and green fluorescent protein pcDNA 3.1 seeded at a density of approximately 900 ng 10.sup.−5 cells, and culture 2 contained HEK293 cells and 25-based pair oligonucleotides seeded at a density of 100 ng 10.sup.−5 cells. Both cultures were placed in a vacuum dessicator and the pressure decreased to −95 kPa over the course of 2 minutes. The vacuum was then released and returned to atmospheric pressure over the course of 10 seconds.
(38) Results & Discussion
(39) This experiment using a prolonged decrease in pressure resulted in nil transfection. No cells expressed GFP and the co-localisation of oligonucleotides and cells was negligible. When compared to Example 1, the magnitude of the decrease in pressure was substantially greater (a 95 kPa decrease, as opposed to a 20 kPa decrease in Example 1). However, the rate of decrease was substantially slower. In Example 1, it is estimated that the rate in which the transient decrease in pressure occurs (dP/d.sub.t) is −35.4×10.sup.6 kPa s.sup.−1. In the present example, the dP/d.sub.t is approximately −0.8 kPa s.sup.−1. Accordingly, dP/d.sub.t may play a role in permeabilising the cell membrane as the cell membrane is gas permeable, such that if dP/d.sub.t is too low gas transfer will occur naturally through the cell membrane without permeabilising the membrane. Once dP/d.sub.t is sufficient, it is thought that the physical properties of cell membrane will not be able to accommodate for rapid gas transfer from the intracellular environment to the extracellular environment. Thus, the cell membrane may be stressed to a point where pores form, thereby allowing the introduction of exogenous material into the cell.
Example 3
(40)
(41)
(42)
(43)
(44) Preferred embodiments of a device design of the invention are depicted in
(45) According to the embodiment shown in
(46) According to the embodiment shown in
(47) According to the embodiment shown in
(48) Suitable ranges for particularly preferred embodiments of the invention as shown in the figures are provided below:
(49) Post diameter range (d.sub.p): 10 nm-5 mm;
(50) Number of columns (n.sub.c): 1-10,000;
(51) Number of rows (n.sub.r): 3-10,000;
(52) Gap range (g): 10 nm-5 mm;
(53) Shift (s): 0-5 mm;
(54) Column pitch (p.sub.c): 30 nm-50 mm; and
(55) Row pitch (p.sub.r) 30 nm-50 mm
(56) The disclosure of every patent, patent application, and publication cited herein is hereby incorporated herein by reference in its entirety.
(57) The citation of any reference herein should not be construed as an admission that such reference is available as “Prior Art” to the instant application.
(58) Throughout the specification the aim has been to describe the preferred embodiments of the invention without limiting the invention to any one embodiment or specific collection of features. Those of skill in the art will therefore appreciate that, in light of the instant disclosure, various modifications and changes can be made in the particular embodiments exemplified without departing from the scope of the invention. All such modifications and changes are intended to be included within the scope of the appended claims.